(Q35035091)

5 August 2017

1 reference

title

Caspofungin acetate for treatment of invasive fungal infections (English)

1 reference

invasive fungal infections

5 August 2017

1 reference

Staci A Pacetti

1

1 reference

PubMed ID

12503942

5 August 2017

Steven P Gelone

series ordinal

2

1 reference

PubMed ID

12503942

5 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Annals of Pharmacotherapy

5 August 2017

1 reference

5 August 2017

37

1 reference

5 August 2017

1

1 reference

5 August 2017

90-98

1 reference

In vitro antifungal susceptibility testing

5 August 2017

1 reference

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

21 January 2018

1 reference

Invasive aspergillosis in 2002: an update

21 January 2018

1 reference

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States

21 January 2018

1 reference

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

21 January 2018

1 reference

Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

21 January 2018

1 reference

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

Antifungal agents. Part I. Amphotericin B preparations and flucytosine

21 January 2018

1 reference

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study

21 January 2018

1 reference

Lipid formulations of amphotericin B: clinical efficacy and toxicities

21 January 2018

1 reference

Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro

21 January 2018

1 reference

In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans

21 January 2018

1 reference

Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice

21 January 2018

1 reference

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

21 January 2018

1 reference

Antifungal agents. Part II. The azoles

21 January 2018

1 reference

Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate

21 January 2018

1 reference

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis

21 January 2018

1 reference

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

21 January 2018

1 reference

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

21 January 2018

1 reference

In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.

21 January 2018

1 reference

Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study

21 January 2018

1 reference

Voriconazole: a new triazole antifungal

21 January 2018

1 reference

Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.

21 January 2018

1 reference

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

21 January 2018

1 reference

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

21 January 2018

1 reference

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

Mortality and costs of acute renal failure associated with amphotericin B therapy

21 January 2018

1 reference

An overview of fungal infections

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C114

1 reference

5 August 2017

1 reference

PubMed ID

12503942